Bond Anglo-American Tobacco 8.125% ( US544152AA92 ) in USD

Anglo-American Tobacco

100 % ⇌

United Kingdom

US544152AA92 ( in USD )

8.125% per year ( payment 2 times a year)

23/06/2019 - Bond has expired

Prospectus brochure of the bond British American Tobacco US544152AA92 in USD 8.125%, expired

1 000 USD

666 979 000 USD

544152AA9

N/A

British American Tobacco is a multinational tobacco company headquartered in London, England, manufacturing and selling cigarettes and other tobacco products globally under various brands.

The Bond issued by Anglo-American Tobacco ( United Kingdom ) , in USD, with the ISIN code US544152AA92, pays a coupon of 8.125% per year.
The coupons are paid 2 times per year and the Bond maturity is 23/06/2019

424(b)(2)
Page 1 of 110
424B2 1 g19413bte424b2.htm 424(B)(2)
file://\\23filesrv01\ljs\Tamara\Lorillard Tobacco Comp, 8.125% Sr Nts due 2019.htm
6/26/2009

424(b)(2)
Page 2 of 110
Table of Contents
As filed pursuant to Rule 424(b)(2)
Registration Nos. 333-159902, 333-159902-01

CALCULATION OF REGISTRATION FEE

Title of Each Class
Amount to be
Maximum Offering Maximum Aggregate Amount of Registration
of Securities to be Registered

Registered

Price Per Unit

Offering Price

Fee(1)
8.125% Senior Note due
2019
$750,000,000
100%

$750,000,000
$41,850

(1) Calculated in accordance with Rule 457(r) under the Securities Act of 1933 (the "Securities Act").

PROSPECTUS SUPPLEMENT
(To Prospectus dated June 11, 2009)

$750,000,000

Lorillard Tobacco Company

8.125% Senior Notes due June 23, 2019

Guaranteed by
Lorillard, Inc.

This is an offering of an aggregate of $750,000,000 8.125% Senior Notes due June 23, 2019 (which
we refer to as the "notes"). We will pay interest on the notes on June 23 and December 23 of each year,
beginning December 23, 2009. The notes will bear interest at a rate of 8.125% per year and will mature on
June 23, 2019. The interest rate will be subject to adjustment under the circumstances described under
"Description of Notes -- Interest Rate Adjustment" in this prospectus supplement.

Upon the occurrence of both (a) a change of control of Lorillard Tobacco Company and (b) a
downgrade of the notes below an investment grade rating by each of Moody's Investors Services, Inc. (or
"Moody's") and Standard & Poor's Ratings Services (or "S&P") within a specified period, we will be
required to make an offer to purchase the notes at a price equal to 101% of their principal amount, plus
accrued and unpaid interest, if any, to the date of repurchase. See "Description of Notes -- Repurchase
Upon Change of Control Triggering Event."

The notes will be senior unsecured obligations of Lorillard Tobacco Company and will rank equally
with all of its other existing and future senior unsecured indebtedness. Lorillard Tobacco Company is the
principal wholly owned operating subsidiary of Lorillard, Inc. The notes will be fully and unconditionally
guaranteed on a senior unsecured basis by our ultimate parent company Lorillard, Inc. The guarantee will
rank equally with all of Lorillard, Inc.'s existing and future senior unsecured indebtedness and guarantees
from time to time outstanding. The notes will be denominated in U.S. dollars and issued only in
denominations of $1,000 and integral multiples of $1,000, in excess of $1,000.

There is currently no public market for the notes. The notes have been authorized to be listed on the
New York Stock Exchange, subject to notice of issuance.

Investing in the notes involves risks. See the "Risk Factors" section in Lorillard,
Inc.'s Annual Report on Form 10-K for the year ended December 31, 2008 and
those contained in our most recent Quarterly Report on Form 10-Q for the period
ended March 31, 2009 and the "Risk Factors" section beginning on page S-5 of this
prospectus supplement.

Public Offering Underwriting Proceeds to Us

Price
Discount (Before Expenses)

Per 8.125% Senior Note due 2019

100%
0.65%
99.35%
file://\\23filesrv01\ljs\Tamara\Lorillard Tobacco Comp, 8.125% Sr Nts due 2019.htm
6/26/2009

424(b)(2)
Page 3 of 110
Total
$ 750,000,000 $ 4,875,000 $ 745,125,000

Interest will accrue from June 23, 2009.

The underwriters expect to deliver the notes through the facilities of The Depository Trust Company,
including its participants Clearstream Banking, société anonyme, Luxembourg or Euroclear Bank
S.A./N.V., as operator of the Euroclear System, against payment in New York, New York on or about
June 23, 2009.

Neither the Securities and Exchange Commission nor any other regulatory body has approved
or disapproved of these securities or determined if this prospectus supplement or the attached
prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

Joint Book-Running Managers
Barclays Capital

J.P. Morgan

Goldman, Sachs & Co.

Wachovia Securities

Co-Managers
CALYON
RBS

The date of this prospectus supplement is June 18, 2009
file://\\23filesrv01\ljs\Tamara\Lorillard Tobacco Comp, 8.125% Sr Nts due 2019.htm
6/26/2009

424(b)(2)
Page 4 of 110

TABLE OF CONTENTS

SUMMARY
S-1
RISK FACTORS
S-5
USE OF PROCEEDS
S-9
RATIO OF EARNINGS TO FIXED CHARGES
S-9
CAPITALIZATION
S-10
SELECTED FINANCIAL INFORMATION
S-11
DESCRIPTION OF NOTES
S-12
CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS
S-21
UNDERWRITING
S-25
LEGAL MATTERS
S-27
EXPERTS
S-27
DOCUMENTS INCORPORATED BY REFERENCE
S-27

PROSPECTUS

Page

ABOUT THIS PROSPECTUS
1
FORWARD-LOOKING STATEMENTS
1
OUR COMPANY
3
GENERAL DESCRIPTION OF SECURITIES WE MAY OFFER
4
RISK FACTORS
4
USE OF PROCEEDS
4
RATIO OF EARNINGS TO FIXED CHARGES
4
DESCRIPTION OF DEBT SECURITIES
5
DESCRIPTION OF GUARANTEES OF DEBT SECURITIES
17
DESCRIPTION OF LORILLARD, INC.'S CAPITAL STOCK
18
DESCRIPTION OF WARRANTS
22
PLAN OF DISTRIBUTION
23
LEGAL MATTERS
25
EXPERTS
25
WHERE YOU CAN FIND MORE INFORMATION
25
DOCUMENTS INCORPORATED BY REFERENCE
25

You should rely only on the information contained or incorporated by reference in this
prospectus supplement, any related free writing prospectus and the attached prospectus. We
have not, and the underwriters have not, authorized anyone to provide you with different
information. If anyone provides you with different or inconsistent information, you should not
rely on it. If the information varies between this prospectus supplement and the attached
prospectus, the information in this prospectus supplement supersedes the information in the
attached prospectus. We are not making an offer of these securities in any jurisdiction where the
offer or sale is not permitted. Neither the delivery of this prospectus supplement, any related
free writing prospectus or the attached prospectus, nor any sale made hereunder and
thereunder, shall under any circumstances create any implication that there has been no change
in our affairs since the date of this prospectus supplement, any related free writing prospectus
or the attached prospectus, regardless of the time of delivery of such document or any sale of the
securities offered hereby or thereby, or that the information contained or incorporated by
reference herein or therein is correct as of any time subsequent to the date of such information.
file://\\23filesrv01\ljs\Tamara\Lorillard Tobacco Comp, 8.125% Sr Nts due 2019.htm
6/26/2009

424(b)(2)
Page 5 of 110
Table of Contents

The distribution of this prospectus supplement and the attached prospectus and the offering or sale
of the notes in some jurisdictions may be restricted by law. The notes are offered for sale in those
jurisdictions in the United States and Europe where it is lawful to make such offers. Persons into
whose possession this prospectus supplement and the attached prospectus come are required by us and
the underwriters to inform themselves about, and to observe, any applicable restrictions. This
prospectus supplement and the attached prospectus may not be used for or in connection with an offer
or solicitation by any person in any jurisdiction in which that offer or solicitation is not authorized or
to any person to whom it is unlawful to make that offer or solicitation. See "Underwriting -- Offering
Restrictions" in this prospectus supplement.

This prospectus supplement and the attached prospectus have been prepared on the basis that any
offer of notes in any Member State of the European Economic Area that has implemented the
Prospectus Directive (2003/71/EC) (each, a "Relevant Member State") will be made pursuant to an
exemption under the Prospectus Directive, as implemented in that Relevant Member State, from the
requirement to publish a prospectus for offers of notes. Accordingly, any person making or intending
to make an offer of notes within the European Economic Area may only do so in circumstances in
which no obligation arises for us or any of the underwriters to publish a prospectus pursuant to
Article 3 of the Prospectus Directive in relation to such offer. Neither we nor the underwriters have
authorized, nor do we nor they authorize, the making of any offer of notes in circumstances in which
an obligation arises for us or the underwriters to publish a prospectus for such offer.

ABOUT THIS PROSPECTUS SUPPLEMENT

This prospectus supplement contains the terms of this offering of notes. This prospectus
supplement, or the information incorporated by reference, may add, update or change information in
the attached prospectus. If information in this prospectus supplement, or the information incorporated
by reference in this prospectus supplement, is inconsistent with the attached prospectus, this
prospectus supplement, or the information incorporated by reference in this prospectus supplement,
will apply and will supersede that information in the attached prospectus.

It is important for you to read and consider all information contained in this prospectus
supplement, the attached prospectus and any related free writing prospectus in making your
investment decision. You should also read and consider the information in the documents we have
referred you to under "Documents Incorporated by Reference" in this prospectus supplement and
under "Where You Can Find More Information" in the attached prospectus.

Unless we have indicated otherwise or the context otherwise requires, references in this
prospectus supplement to "Lorillard," "Company," "we," "us," "our" and similar terms refer to
Lorillard, Inc., a Delaware corporation, and its subsidiaries, unless otherwise specified or
otherwise required. Lorillard, Inc. refers solely to the parent company and "Lorillard Tobacco"
or the "Issuer" refers solely to Lorillard Tobacco Company, a Delaware corporation, the
principal wholly owned operating subsidiary of Lorillard, Inc.

Unless otherwise specified, market share data in this prospectus supplement and incorporated by
reference herein is based on data made available by Management Science Associates, Inc. ("MSAI"),
an independent third-party database management organization that collects wholesale shipment data
from various cigarette manufacturers. MSAI divides the cigarette market into two price segments, the
premium price segment and the discount or reduced price segment. MSAI's information relating to
unit sales volume and market share of certain of the smaller, primarily deep discount, cigarette
manufacturers is based on estimates derived by MSAI. We believe that volume and market share
information for deep discount manufacturers may be understated and, correspondingly, market share
information for the larger manufacturers, including us, may be overstated by MSAI.

FORWARD-LOOKING STATEMENTS

Investors are cautioned that certain statements contained in this prospectus are "forward-looking"
statements. Forward-looking statements include, without limitation, any statement that may project,
indicate or imply future results, events, performance or achievements, and may contain the words
"expect," "intend," "plan," "anticipate," "estimate," "believe," "will be," "will continue," "will likely
result," and similar expressions. In addition, any statement concerning future financial performance
(including future revenues, earnings or growth rates), ongoing business strategies or prospects, and
possible actions taken by us, which may be provided by our management team are also forward-
file://\\23filesrv01\ljs\Tamara\Lorillard Tobacco Comp, 8.125% Sr Nts due 2019.htm
6/26/2009

424(b)(2)
Page 6 of 110
looking statements as defined by the Private Securities Litigation Reform Act of 1995.

S-ii
file://\\23filesrv01\ljs\Tamara\Lorillard Tobacco Comp, 8.125% Sr Nts due 2019.htm
6/26/2009

424(b)(2)
Page 7 of 110
Table of Contents

Forward-looking statements are based on current expectations and projections about future events
and are inherently subject to a variety of risks and uncertainties, many of which are beyond the control
of our management team, which could cause actual results to differ materially from those anticipated
or projected. These risks and uncertainties include, among others:

· the outcome of pending litigation;

· health concerns, claims and regulations relating to the use of tobacco products and exposure to
environmental tobacco smoke;

· legislation, including actual and potential federal and state excise tax increases, and the effects
of tobacco litigation settlements on pricing and consumption rates;

· continued intense competition from other cigarette manufacturers, including significant levels of
promotional activities and the presence of a sizable deep discount category;

· the continuing decline in volume in the domestic cigarette industry;

· increasing marketing and regulatory restrictions, governmental regulation and privately imposed
smoking restrictions;

· the possibility of restrictions or bans on the use of certain ingredients, including menthol, in
cigarettes, or the use of certain flavor descriptors in the marketing of cigarettes;

· litigation, including risks associated with adverse jury and judicial determinations, courts
reaching conclusions at variance with the general understandings of applicable law, bonding
requirements and the absence of adequate appellate remedies to get timely relief from any of the
foregoing;

· general economic and business conditions;

· changes in financial markets (such as interest rate, credit, currency, commodities and equities
markets) or in the value of specific investments;

· potential changes in accounting policies by the Financial Accounting Standards Board, the
Securities and Exchange Commission (the "Commission" or the "SEC") or regulatory agencies
for the industry in which we participate that may cause us to revise our financial accounting
and/or disclosures in the future, and which may change the way analysts measure our business
or financial performance;

· the risk of fire, violent weather or other disasters adversely affecting our production, storage and
other facilities;

· changes in the price, quality or quantity of tobacco leaf and other raw materials available for use
in our cigarettes;

· reliance on a limited number of suppliers for certain raw materials;

· the impact of regulatory initiatives, including the regulation of cigarettes by the Food and Drug
Administration, and compliance with governmental regulations, judicial rulings and jury
verdicts, including our ability to obtain surety bonds with regard to adverse judgments;

· our ability to attract and retain the best talent to implement our strategies as a result of the
decreasing social acceptance of cigarettes;

· the availability of financing upon favorable terms and the results of our financing efforts; and

· the closing of any contemplated transactions and agreements.

Adverse developments in any of these factors, as well as the risks and uncertainties described in
"Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of
Operations -- Business Environment" and elsewhere in our Annual Report on Form 10-K for the year
ended December 31, 2008, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2009,
and this prospectus supplement, could cause our results to differ materially from results that have been
or may be anticipated or projected. Forward-looking statements speak only as of the date of this
prospectus and we expressly disclaim any obligation or undertaking to update these statements to
reflect any change in expectations or beliefs or any change in events, conditions or circumstances on
which any forward-looking statement is or may be based.

S-iii
file://\\23filesrv01\ljs\Tamara\Lorillard Tobacco Comp, 8.125% Sr Nts due 2019.htm
6/26/2009

424(b)(2)
Page 8 of 110
file://\\23filesrv01\ljs\Tamara\Lorillard Tobacco Comp, 8.125% Sr Nts due 2019.htm
6/26/2009

424(b)(2)
Page 9 of 110
Table of Contents

SUMMARY

This summary highlights selected information from this prospectus supplement and the
accompanying prospectus and may not contain all of the information that may be important to
you. To understand the terms of the securities being offered by this prospectus supplement, you
should read this entire prospectus supplement, the accompanying prospectus and the documents
identified in the prospectus under the caption "Where You Can Find More Information."

Our Company

Lorillard is the third largest manufacturer of cigarettes in the United States. Founded in
1760, Lorillard is the oldest continuously operating tobacco company in the United States.
Newport, our flagship menthol flavored premium cigarette brand, is the top selling menthol and
second largest selling cigarette brand overall in the United States based on gross units sold in
the full year 2008 and in the first three months of 2009. The Newport brand accounted for
approximately 93.7% and 93.2% of our sales revenue for the fiscal year ended December 31,
2008 and the three months ended March 31, 2009, respectively. In addition to the Newport
brand, our product line has five additional brand families marketed under the Kent, True,
Maverick, Old Gold and Max brand names. These six brands include 44 different product
offerings which vary in price, taste, flavor, length and packaging. In the United States and
certain U.S. possessions and territories, we shipped 37.8 billion cigarettes in the full year 2008
and 7.9 billion cigarettes in the first three months of 2009. We sold our major trademarks
outside of the United States in 1977. We manufacture all of our products at our Greensboro,
North Carolina facility.

We produce cigarettes for both the premium and discount segments of the domestic
cigarette market. We do not compete in a subcategory of the discount segment that we identify
as the deep discount segment. Premium brands are well known, established brands marketed at
higher retail prices. Discount brands are generally less well recognized brands marketed at
lower retail prices. We define the deep discount subcategory to include brands sold at the lowest
retail prices. Deep discount cigarettes are typically manufactured by smaller companies, relative
to us and other major U.S. manufacturers, many of which have no, or significantly lower,
payment obligations under the State Settlement Agreements, consisting of the Master Settlement
Agreement among major tobacco manufacturers and 46 states and various other governments
and jurisdictions (the "MSA") and the settlements of similar claims brought by Mississippi,
Florida, Texas and Minnesota (the "Initial State Settlements").

In addition, in 2006 we entered into a joint venture with Swedish Match North America to
develop and evaluate the opportunity to market a smokeless tobacco product for the
U.S. market, called Triumph Snus. We commenced test marketing of Triumph Snus in Ohio in
January and Georgia in May of 2008. If successful, our current test marketing may permit us to
position Triumph Snus for broader testing or expanded distribution with limited capital
investment.

Prior to June 10, 2008, Lorillard, Inc. was a wholly owned subsidiary of Loews Corporation
(which we refer to as "Loews"), a publicly traded company listed on the New York Stock
Exchange (which we refer to as the "NYSE"). Our results of operations and financial condition
were included as a separate reporting segment in Loews's financial statements and filings with
the SEC. Beginning in 2002 and through June 10, 2008, Loews had also issued a separate class
of its common stock, referred to as the "Carolina Group Stock," to track the economic
performance of Loews's 100% interest in Lorillard, Inc. and certain liabilities, costs and
expenses of Loews and Lorillard arising out of or related to tobacco or tobacco-related
businesses. On June 10, 2008, we began operating as an independent, publicly traded company
pursuant to our separation from Loews (the "Separation"). In connection with the Separation,
we entered into a Separation Agreement with Loews to provide for the separation of our
business from Loews as well as providing for indemnification and allocation of taxes between
the parties.

file://\\23filesrv01\ljs\Tamara\Lorillard Tobacco Comp, 8.125% Sr Nts due 2019.htm
6/26/2009

424(b)(2)
Page 10 of 110
Our principal executive offices are located at 714 Green Valley Road, Greensboro, NC
27408, our telephone number is (336) 335-7000, and our website is www.lorillard.com. The
information contained in, or that can be accessed through, our website is not a part of this
prospectus supplement.

S-1
file://\\23filesrv01\ljs\Tamara\Lorillard Tobacco Comp, 8.125% Sr Nts due 2019.htm
6/26/2009